MultiPoint™ pacing CRT technology shows promise in improving heart failure responder rates

952

A growing body of evidence, including the most recent randomised clinical trial results presented at HRS and CARDIOSTIM-EHRA EUROPACE, has shown that cardiac resynchronisation therapy (CRT) with MultiPoint™ pacing technology from St. Jude Medical shows promise in improving response rates in heart failure patients.

Cardiac Rhythm News reviewed key data and also spoke to Dr. Andrew Flett (University Hospital Southampton, Southampton, UK) and Dr. Timothy Betts (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) about their experience using MultiPoint™ pacing in their clinical practice.

(Visited 434 times, 1 visits today)